Basics |
PharmaCyte Biotech, Inc.
|
IPO Date: |
December 5, 2003 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$6.46M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.06 | 2.61%
|
Avg Daily Range (30 D): |
$0.04 | 3.67%
|
Avg Daily Range (90 D): |
$0.03 | 3.11%
|
Institutional Daily Volume |
Avg Daily Volume: |
.46M |
Avg Daily Volume (30 D): |
.06M |
Avg Daily Volume (90 D): |
.03M |
Trade Size |
Avg Trade Size (Sh.): |
235 |
Avg Trade Size (Sh.) (30 D): |
262 |
Avg Trade Size (Sh.) (90 D): |
249 |
Institutional Trades |
Total Inst.Trades: |
16 |
Avg Inst. Trade: |
$1.4M |
Avg Inst. Trade (30 D): |
$1.07M |
Avg Inst. Trade (90 D): |
$1.07M |
Avg Inst. Trade Volume: |
.37M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$.52M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
209.41K |
|
|
Financials |
|
TTM |
Q4 2025 |
FY 2025 |
Basic EPS
|
$3.19
|
$1.52
|
$3.19
|
Diluted EPS
|
$3.19
|
$1.52
|
$3.19
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ 30.66M
|
$ 11.75M
|
$ 30.66M
|
Operating Income / Loss
|
$ -4.38M
|
$ -1.04M
|
$ -4.38M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -35.01M
|
$ -1.21M
|
$ -35.01M
|
PE Ratio
|
0.35
|
|
|
Splits |
Jul 12, 2021:
1:1500
|
Dec 08, 2003:
3:1
|
|
|
|